| Optiscan Imaging Limited (OIL) ORDINARY FULLY PAID |
Health Care |
$162 |
Optiscan Submits InSpecta FDA Dossier
|
31 Mar 2026 9:30AM |
$0.105 |
$0.155 |
risen by
47.62%
|
|
OIL - Price-sensitive ASX Announcement
Full Release
Key Points
- Optiscan submits FDA dossier for InSpecta®
- Critical milestone towards U.S. veterinary market entry
- Reflects maturity in technology and processes
- Supports expansion of clinical reference sites
- Foundation for future regulatory activities
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Latrobe Magnesium Limited (LMG) ORDINARY FULLY PAID |
Materials |
$41 |
MX Prepayment
|
31 Mar 2026 9:30AM |
$0.020 |
$0.012 |
fallen by
40%
|
|
LMG - Price-sensitive ASX Announcement
Full Release
Key Points
- LMG receives USD 2 million prepayment from Metal Exchange LLC.
- Prepayment supports the installation and commissioning of LMG's Demonstration Plant.
- Structured pricing framework includes a floor price mechanism for revenue certainty.
- All magnesium production allocated to the U.S. market.
- No U.S. customs tariff on Australian magnesium enhances competitiveness.
- Potential strategic alignment and equity investment discussions with MX.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Xamble Group Limited (XGL) CHESS DEPOSITARY INTERESTS 1:1 |
Communication Services |
$5 |
Appendix 4G
|
31 Mar 2026 9:30AM |
$0.012 |
$0.009 |
fallen by
25%
|
|
| Xamble Group Limited (XGL) CHESS DEPOSITARY INTERESTS 1:1 |
Communication Services |
$5 |
Annual Report to shareholders
|
31 Mar 2026 9:30AM |
$0.012 |
$0.009 |
fallen by
25%
|
|
| Credit Corp Group Limited (CCP) ORDINARY FULLY PAID |
Financials |
$896 |
Change in substantial holding
|
31 Mar 2026 9:29AM |
$10.150 |
$13.170 |
risen by
29.75%
|
|
| Enlitic Inc (ENL) CHESS DEPOSITARY INTERESTS 1:1 US PROHIBITED |
Health Care |
$6 |
Contract Secured with St. Jude Childrens Research Hospital
|
31 Mar 2026 9:28AM |
$0.007 |
$0.007 |
fallen by
0%
|
|
ENL - Price-sensitive ASX Announcement
Full Release
Key Points
- Contract secured between Enlitic Inc and St. Jude Children’s Research Hospital.
- The contract is valued at US$250,000 for data migration services.
- Potential for adoption of Enlitic’s AI-powered data management platform, Ensight.
- First commercial engagement in the paediatric healthcare sector for Enlitic.
- The contract adds to US$1.75 million in new contracts for March.
- Ensight platform offers SaaS imaging solutions for large-scale medical datasets.
- Enlitic’s CEO highlights strategic validation and need for extended data management solutions.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Insurance Australia Group Limited (IAG) ORDINARY FULLY PAID |
Financials |
$19,452 |
Update - Notification of buy-back - IAG
|
31 Mar 2026 9:27AM |
$7.380 |
$8.320 |
risen by
12.74%
|
|
| Clime Capital Limited (CAM) ORDINARY FULLY PAID |
Financials |
$96 |
Update - Notification of buy-back - CAMG
|
31 Mar 2026 9:27AM |
$0.710 |
$0.685 |
fallen by
3.52%
|
|
| Macarthur Minerals Limited (MIO) ORDINARY FULLY PAID |
Materials |
$7 |
Proposed issue of securities - MIO
|
31 Mar 2026 9:27AM |
$0.026 |
$0.019 |
fallen by
26.92%
|
|
| Macarthur Minerals Limited (MIO) ORDINARY FULLY PAID |
Materials |
$7 |
Macarthur Minerals Receives Firm Placement Commitments
|
31 Mar 2026 9:27AM |
$0.026 |
$0.019 |
fallen by
26.92%
|
|
MIO - Price-sensitive ASX Announcement
Full Release
Key Points
- Firm commitments to raise A$1.25 million through placement.
- Placement oversubscribed with scaling back of applications.
- Issue price of A$0.025 per share, 23% discount to the average price.
- Funds to support Lake Giles Iron Project and corporate costs.
- Options provided for every two shares subscribed.
- Placement made under ASX Listing Rules 7.1 and 7.1A.
- Targeting sophisticated and professional investors under Australian law.
- Focus on maintaining project portfolio in good standing.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Rhythm Biosciences Limited (RHY) ORDINARY FULLY PAID |
Health Care |
$31 |
RHYO Options Underwriting Agreement
|
31 Mar 2026 9:25AM |
$0.195 |
$0.087 |
fallen by
55.38%
|
|
| Way 2 Vat Ltd (W2V) ORDINARY FULLY PAID |
Information Technology |
$15 |
Corporate Governance Statement and Appendix 4G
|
31 Mar 2026 9:24AM |
$0.074 |
$0.058 |
fallen by
21.62%
|
|
| Kip McGrath Education Centres Limited (KME) ORDINARY FULLY PAID |
Consumer Discretionary |
$26 |
Update - Notification of buy-back - KME
|
31 Mar 2026 9:23AM |
$0.560 |
$0.490 |
fallen by
12.50%
|
|
| Highfield Resources Limited (HFR) ORDINARY FULLY PAID |
Materials |
$10 |
Notice Required Under ASX Listing Rule 3.13.1
|
31 Mar 2026 9:23AM |
$0.018 |
$0.021 |
risen by
16.67%
|
|
| Way 2 Vat Ltd (W2V) ORDINARY FULLY PAID |
Information Technology |
$15 |
Annual Report to shareholders
|
31 Mar 2026 9:22AM |
$0.074 |
$0.058 |
fallen by
21.62%
|
|
| Olympio Metals Limited (OLY) ORDINARY FULLY PAID |
Materials |
$8 |
19.4m @ 17.29g/t Gold Intercept in Hole BO-26-63 at Bousqet
|
31 Mar 2026 9:21AM |
$0.055 |
$0.047 |
fallen by
14.55%
|
|
OLY - Price-sensitive ASX Announcement
Full Release
Key Points
- Olympio Metals Limited announced final assay results from hole BO-26-63 at Bousquet.
- Hole BO-26-63 returned 19.40m @ 17.29 g/t Au from 172.5m, including intervals with visible gold.
- The intercept suggests multiple high-grade lodes in the 'Main Lode' zone at Paquin.
- Olympio has the option to acquire an 80% interest in the Bousquet Project.
- Assays are pending for the remaining 6 drill holes of the Phase 2 drill program.
- Olympio is planning further exploration to understand the size and geometry of the gold lodes.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Amotiv Limited (AOV) ORDINARY FULLY PAID |
Consumer Discretionary |
$874 |
Appendix 3Y - Change of Director's Interest Notice
|
31 Mar 2026 9:20AM |
$6.680 |
$6.530 |
fallen by
2.25%
|
|
| Papyrus Australia Limited (PPY) ORDINARY FULLY PAID |
Materials |
$6 |
Monthly Activities/Appendix 4C Cash Flow Report
|
31 Mar 2026 9:20AM |
$0.009 |
$0.009 |
fallen by
0%
|
|
PPY - Price-sensitive ASX Announcement
Full Release
Key Points
- Papyrus Australia continued operational momentum through February 2026.
- The Adelaide Rapid Prototyping & R&D Facility was commissioned and started operations.
- Focus on optimizing pulp furnish and equipment design for scale-up.
- Produced moulded product samples and pulp for TBS contract board trials.
- Released Interim Financial Report for the half-year ending December 2025.
- No related party payments were made in February 2026.
- Net cash used in operating activities was $52,000 for February 2026.
- Net cash from financing activities was $1,000, with a loan facility of $750,000.
- Cash at the end of February was $344,000, including $239,000 held in Egypt.
- Total available funding at month end was $594,000 with an estimated 11.42 months of funding available.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Clarity Pharmaceuticals Ltd (CU6) ORDINARY FULLY PAID |
Health Care |
$866 |
Co-PSMA data published in the European Urology journal
|
31 Mar 2026 9:20AM |
$3.030 |
$2.320 |
fallen by
23.43%
|
|
| EBR Systems Inc (EBR) CDI 10:1 US PERSON PROHIBITED EXCLUDING QIB |
Health Care |
$267 |
Correction of Annual Report
|
31 Mar 2026 9:18AM |
$0.580 |
$0.355 |
fallen by
38.79%
|
|
| Ironbark Balanced Income Limited (IBC) ORDINARY FULLY PAID |
Financials |
$43 |
Update - Notification of buy-back - IBC
|
31 Mar 2026 9:18AM |
$0.420 |
$0.430 |
risen by
2.38%
|
|
| Turaco Gold Limited (TCG) ORDINARY FULLY PAID |
Materials |
$523 |
Annual Report to shareholders
|
31 Mar 2026 9:17AM |
$0.600 |
$0.485 |
fallen by
19.17%
|
|
| Hawk Resources Limited (HWK) ORDINARY FULLY PAID |
Materials |
$19 |
Proposed issue of securities - HWK
|
31 Mar 2026 9:16AM |
$0.039 |
$0.028 |
fallen by
28.21%
|
|
| Right Resources Limited (RRE) ORDINARY FULLY PAID |
Materials |
$9 |
$1.1m R&D Cash Inflows and Ongoing CODES Partnership
|
31 Mar 2026 9:16AM |
$0.115 |
$0.099 |
fallen by
13.91%
|
|
RRE - Price-sensitive ASX Announcement
Full Release
Key Points
- Received A$719,577 R&D Tax Incentive refund for FY2025.
- Secured a A$930,000 R&D funding facility for FY2026.
- Continued collaboration with CODES focuses on geological studies.
- Advances in understanding gold and copper systems in Tumbarumba.
- R&D initiatives support ongoing exploration strategy.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Freehill Mining Limited (FHS) ORDINARY FULLY PAID |
Materials |
$8 |
Appointment and Resignation of Company Secretary
|
31 Mar 2026 9:16AM |
$0.001 |
$0.002 |
risen by
100%
|
|